Cargando…
Patients’ experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study
PURPOSE: The experiences of patients with diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor (CAR) T-cell therapy have received little attention. This study aimed to explore the treatment experiences of patients with relapsed or refractory (R/R) B-cell lymphoma during CAR T...
Autores principales: | Mao, Yiwen, Huang, Lihong, Ruan, Haitao, Guo, Yue, Ni, Sha, Ling, Yuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131511/ https://www.ncbi.nlm.nih.gov/pubmed/37099077 http://dx.doi.org/10.1007/s00520-023-07763-x |
Ejemplares similares
-
Chimeric antigen receptor-T-cell therapy: China leading the way
por: Gale, Robert Peter
Publicado: (2022) -
Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017) -
Assessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro
por: Wong, Kuan Un, et al.
Publicado: (2022) -
Chimeric antigen receptors that trigger phagocytosis
por: Morrissey, Meghan A, et al.
Publicado: (2018) -
Chimeric Antigen Receptors for T-Cell Malignancies
por: Scherer, Lauren D., et al.
Publicado: (2019)